Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03093935 · ClinicalTrials.gov registry record · NA
StimRouter™ for Pain Management in Post-stroke Shoulder Pain
A NA study, sponsored by Bioness.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03093935: Clinical Trial NA study, sponsored by Bioness.
NCT03093935 is a NA study that was terminated before completion, run by Bioness. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03093935, a NA study, was terminated before completion, sponsored by Bioness.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
StimRouter Neuromodulation System includes an implanted lead which provides peripheral nerve stimulation for chronic pain. Post-stroke shoulder pain patients will be the focus of this study. After meeting inclusion/exclusion criteria, approximately 50 enrolled patients will participate in the study through 6 months of follow-up. Various measures will be used to assess patient response to use of the device.
Primary Outcome
The Brief Pain Inventory (BPI) form is a standard pain assessment tool based on a 0 to 10 scale. The Average Pain at Rest (BPI question number 5) score will be assessed at Baseline and approximately 3 months after programming (therapy start) to determine if there is a significant reduction in average pain with the addition of StimRouter TM treatment to standard of care.
Interventions
- DEVICE StimRouter Neuromodulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-11-20 |
| Phase | NA |
Why NCT03093935 stopped before completion
NCT03093935 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which StimRouter Neuromodulation System is the first listed.
NCT03093935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03093935 about?
NCT03093935 is a clinical study titled "StimRouter™ for Pain Management in Post-stroke Shoulder Pain". StimRouter Neuromodulation System includes an implanted lead which provides peripheral nerve stimulation for chronic pain. Post-stroke shoulder pain patients will be the focus of this study. After meeting inclusion/exclusion criteria, approximately 50 enrolled patients will participate in the study ...
What is the current status of trial NCT03093935?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2018-07-01. Estimated completion is 2020-11-20.
What interventions are being tested in trial NCT03093935?
The interventions under investigation include: StimRouter Neuromodulation System (DEVICE).
Who is sponsoring clinical trial NCT03093935?
This trial is sponsored by Bioness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03093935's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI